Dietary soy supplements produce opposite effects on anxiety in intact male and female rats in the elevated plus-maze

Behavioral Neuroscience

Volumn 119, Issue 2, 2005, Pages 587-594

  Patisaul, Heather B ^a,b   Blum, Adele ^a   Luskin, Jordan R ^a   Wilson, Mark E ^a  

^a EMORY UNIVERSITY   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Endocrine disruptors; Estrogen; Phytoestrogens; Soy; Stress

Indexed keywords

ESTROGEN; PHYTOESTROGEN; PROGESTERONE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DIESTRUS; DIET SUPPLEMENTATION; ESTROGEN BLOOD LEVEL; FEMALE; MALE; MAZE TEST; NONHUMAN; PROESTRUS; PROGESTERONE BLOOD LEVEL; RAT; SEX DIFFERENCE; SOYBEAN; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; DIETARY SUPPLEMENTS; ESTRUS; FEMALE; MALE; MAZE LEARNING; PHYTOESTROGENS; RATS; RATS, LONG-EVANS; SEX FACTORS; SOYBEAN PROTEINS;

EID: 17444429237     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.119.2.587     Document Type: Article

References (65)

1. Adlercreutz, H., & Mazur, W. (1997). Phyto-oestrogens and Western diseases. Annals of Medicine, 29, 95-120.
2. Alves, S. E., Lopez, V., McEwen, B. S., & Weiland, N. G. (1998). Differential colocalization of estrogen receptor β (ERβ) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: An immunocytochemical study. Neurobiology, 95, 3281-3286.
3. Antoni, F. A. (1993). Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Frontiers in Neuroendocrinology, 14, 76-122.
4. Boettger-Tong, H., Murthy, L., Chiappetta, C., Kirkland, J. L., Goodwin, B., Adlercreutz, H., et al. (1998). A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environmental Health Perspectives, 106, 369-373.
5. Brown, D. A. (2003). Stopwatch (Version 1.5.1) [Computer software]. Emory University, Center for Behavioral Neuroscience. Retrieved from http://www.cbn-atl.org/research/cores/behavioral_software/stopwatch.cfm
6. Brown, N. M., & Setchell, K. D. (2001). Animal models impacted by phytoestrogens in commercial chow: Implications for pathways influenced by hormones. Laboratory Investigation, 81, 735-747.
7. Carrasco, G. A., & Van de Kar, L. D. (2003). Neuroendocrine pharmacology of stress. European Journal of Pharmacology, 463, 235-272.
8. Chang, H. C., Churchwell, M. I., Delclos, K. B., Newbold, R. R., & Doerge, D. R. (2000). Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats. Journal of Nutrition, 130, 1963-1970.
9. Cruz, A. P., Frei, F., & Graeff, F. G. (1994). Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacology Biochemistry and Behavior, 49, 171-176.
10. Degen, G. H., Janning, P., Diel, P., & Bolt, H. M. (2002). Estrogenic isoflavones in rodent diets. Toxicology Letters, 128, 145-157.
11. Demonty, I., Lamarche, B., & Jones, P. J. (2003). Role of isoflavones in the hypocholesterolemic effect of soy. Nutrition Reviews, 61, 189-203.
12. Diaz-Veliz, G., Alarcon, T., Espinoza, C., Dussaubat, N., & Mora, S. (1997). Ketanserin and anxiety levels: Influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats. Pharmacology Biochemistry and Behavior, 58, 637-642.
13. Doerge, D. R., Chang, H. C., Holder, C. L., & Churchwell, M. I. (2000). Enzymatic conjugation of the soy isoflavones, genistein and daidzein and analysis in human blood using liquid chromatography and mass spectrometry. Drug Metabolism and Disposition, 28, 298-307.
14. Fahrbach, S. E., Meisel, R. L., & Pfaff, D. W. (1985). Preoptic implants of estradiol increase wheel running but not the open field activity of female rats. Physiology & Behavior, 35, 985-992.
15. Figueiredo, H. F., Dolgas, C. M., & Herman, J. P. (2002). Stress activation of cortex and hippocampus is modulated by sex and stage of estrus. Endocrinology, 143, 2534-2540.
16. Food and Drug Administration. (1999). Food labeling: Health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Federal Register, 64, 57700-57733.
17. Franke, A., Custer, L., Wang, W., & Yang, S. C. (1998). HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proceedings of the Society for Experimental Biology and Medicine, 217, 263-272.
18. Frankfurt, M., Siegel, R. A., Sim, I., & Wuttke, W. (1986). Estrous cycle variations in cholecystokinin and substance P concentrations in discrete areas of the rat brain. Neuroendocrinology, 42, 226-231.
19. Frye, C. A., & Walf, A. A. (2004). Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behavioral Neuroscience, 118, 306-313.
20. Hartley, D. E., Edwards, J. E., Spiller, C. E., Alom, N., Tucci, S., Seth, P., et al. (2003). The soya isoflavone content of rat diet can increase anxiety and stress hormone release in the male rat. Psychopharmacology (Berlin), 167, 46-53.
21. Herbison, A. E., & Fenelon, V. S. (1995). Estrogen regulation of GABAA receptor subunit mRNA expression in preoptic area and bed nucleus of the stria terminalis of female rat brain. Journal of Neuroscience, 15, 2328-2337.
22. Hogg, S. (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology Biochemistry and Behavior, 54, 21-30.
23. Hoie, L. H., Morgenstern, E. C., Gruenwald, J., Graubaum, H. J., Busch, R., Luder, W., & Zunft, H. J. (2004, April 5). A double-blind placebo-controlled clinical trial compares the cholesterol lowering effects of two different soy protein preparations in hypercholesterolemic subjects. European Journal of Nutrition, 1-7.
24. Huang, R. Q., Fang, M. J., & Dillon, G. H. (1999). The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors. Brain Research. Molecular Brain Research, 67, 177-183.
25. Imhof, J. T., Coelho, Z. M., Schmitt, M. L., Morato, G. S., & Carobrez, A. P. (1993). Influence of gender and age on performance of rats in the elevated plus-maze apparatus. Behavioural Brain Research, 56, 177-180.
26. Itoi, K., Jiang, Y. Q., Iwasaki, Y., & Watson, S. J. (2004). Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. Journal of Neuroendocrinology, 16, 348-355.
27. Johnston, A. L., & File, S. E. (1991). Sex differences in animal tests of anxiety. Physiology & Behavior, 49, 245-250.
28. Kelly, M. J., Qiu, J., Wagner, E. J., & Ronnekleiv, O. K. (2002). Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). Journal of Steroid Biochemistry and Molecular Biology, 83, 187-193.
29. Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., Van Der Saag, P. T., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology, 139, 4252-4263.
30. Kurzer, M. S. (2003). Phytoestrogen supplement use by women. Journal of Nutrition, 133, 1983S-1986S.
31. Lund, T., & Lephart, E. D. (2001). Dietary soy phytoestrogens produce anxiolytic effects in the elevated plus-maze. Brain Research, 913, 180-184.
32. Marcondes, F. K., Miguel, K. J., Melo, L. L., & Spadari-Bratfisch, R. C. (2001). Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiology & Behavior, 74, 435-440.
33. Micevych, P. E., Matt, D. W., & Go, V. L. (1988). Concentrations of cholecystokinin, substance P, and bombesin in discrete regions of male and female rat brain: Sex differences and estrogen effects. Experimental Neurology, 100, 416-425.
34. Millan, M. J. (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70, 83-244.
35. Mitsushima, D., Tin Tin Win, S., & Kimura, F. (2003). Sexual dimorphism in the GABAergic control of gonadotropin release in intact rats. Neuroscience Research, 46, 399-405.
36. Moore, T. O., Karom, M., & O'Farrell, L. (2004). The neurobehavioral effects of phytoestrogens in male Syrian hamsters. Brain Research, 1016, 102-110.
37. Mora, S., Dussaubat, N., & Diaz-Veliz, G. (1996). Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology, 21, 609-620.
38. Morgan, M. A., & Pfaff, D. W. (2001). Effects of estrogen on activity and fear-related behaviors in mice. Hormones and Behavior, 40, 472-482.
39. Ninan, P. T. (1999). The functional anatomy, neurochemistry, and pharmacology of anxiety. Journal of Clinical Psychiatry, 60(Suppl. 22), 12-17.
40. Nomura, M., McKenna, E., Korach, K., Pfaff, D., & Ogawa, S. (2002). Estrogen receptor-β regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Molecular Brain Research, 109, 84-94.
41. Oro, A. E., Simerly, R. B., & Swanson, L. W. (1988). Estrous cycle variations in levels of cholecystokinin immunoreactivity within cells of three interconnected sexually dimorphic forebrain nuclei: Evidence for a regulatory role for estrogen. Neuroendocrinology, 47, 225-235.
42. Patisaul, H. B. (2004). Dietary phytoestrogens. In R. K. Naz (Ed.), Endocrine disrupters: Effects on male and female reproductive systems (2nd ed., pp. 135-174). Boca Raton, FL: CRC Press.
43. Patisaul, H. B., Dindo, M., Whitten, P. L., & Young, L. J. (2001). Soy isoflavone supplements antagonize reproductive behavior and ERα- and ERβ-dependent gene expression in the brain. Endocrinology, 142, 2946-2952.
44. Patisaul, H. B., Melby, M., Whitten, P. L., & Young, L. J. (2002). Genistein affects ERβ- but not ERα-dependent gene expression in the hypothalamus. Endocrinology, 143, 2189-2197.
45. Patisaul, H. B., Whitten, P. L., & Young, L. (1999). Regulation of estrogen receptor beta mRNA in the brain: Opposite effects of 17β-estradiol and the phytoestrogen, coumestrol. Brain Research. Molecular Brain Research, 67, 165-171.
46. Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985). Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149-167.
47. Pellow, S., & File, S. E. (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacology Biochemistry and Behavior, 24, 525-529.
48. Penalvo, J. L., Heinonen, S. M., Nurmi, T., Deyama, T., Nishibe, S., & Adlercreutz, H. (2004). Plant Hgnans in soy-based health supplements. Journal of Agricultural and Food Chemistry, 52, 4133-4138.
49. Perez, J., Zucchi, I., & Maggi, A. (1986). Sexual dimorphism in the response of the GABAergic system to estrogen administration. Journal of Neurochemistry, 47, 1798-1803.
50. Pfaff, D. (1999). Drive. Cambridge, MA: MIT Press.
51. Roy, E. J., & Wade, G. N. (1975). Role of estrogens in androgen-induced spontaneous activity in male rats. Journal of Comparative Physiology: A. Sensory, Neural, and Behavioral Physiology Psychology, 89, 573-579.
52. Rupprecht, R. (2003). Neuroactive steroids: Mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology, 28, 139-168.
53. Scallet, A. C., Wofford, M., Meredith, J. C., Allaben, W. T., & Ferguson, S. A. (2003). Dietary exposure to genistein increases vasopressin but does not alter beta-endorphin in the rat hypothalamus. Toxicological Sciences, 72, 296-300.
54. Scott, L. V., & Dinan, T. G. (2002). Vasopressin as a target for antidepressant development: An assessment of the available evidence. Journal of Affective Disorders, 72, 113-124.
55. Setchell, K. D., Brown, N. M., Desai, P., Zimmer-Nechemias, L., Wolfe, B. E., Brashear, W. T., et al. (2001). Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Journal of Nutrition, 131(Suppl. 4), 1362S-1375S.
56. Setchell, K. D., & Lydeking-Olsen, E. (2003). Dietary phytoestrogens and their effect on bone: Evidence from in vitro and in vivo, human observational, and dietary intervention studies. American Journal of Clinical Nutrition, 78(Suppl. 3), 593S-609S.
57. Shaikh, A. A., & Shaikh, S. A. (1975). Adrenal and ovarian steroid secretion in the rat estrous cycle temporally related to gonadotropins and steroid levels found in peripheral plasma. Endocrinology, 96, 37-44.
58. Shors, T. J. (2004). Learning during stressful times. Learning & Memory, 11, 137-144.
59. Simon, N. G., Kaplan, J. R., Hu, S., Register, T. C., & Adams, M. R. (2004). Increased aggressive behavior and decreased affiliative behavior in adult male monkeys after long-term consumption of diets rich in soy protein and isoflavones. Hormones and Behavior, 45, 278-284.
60. Smith, M. S., Freeman, M. E., & Neill, J. D. (1975). The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: Prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology, 96, 219-226.
61. Thigpen, J. E., Setchell, K. D. R., Ahlmark, K. B., Locklear, J., Spahr, T., Caviness, G. F., et al. (1999). Phytoestrogen content of purified open-and closed-formula laboratory animal diets. Laboratory Animal Science, 49, 530-536.
62. Whitten, P. L., Lewis, C., Russell, E., & Naftolin, F. (1995). Phytoestrogen influences on the development of behavior and gonadotropin function. Proceedings of the Society for Experimental Biology and Medicine, 208, 82-86.
63. Worthman, C. M., & Stallings, J. F. (1997). Hormone measures in finger-prick blood spot samples: New field methods for reproductive endocrinology. American Journal of Physical Anthropology, 104, 1-21.
64. Worthman, C., Stallings, J., & Hoffman, L. (1990). Sensitive salivary estradiol assay for monitoring ovarian function. Clinical Chemistry, 36, 1769-1773.
65. Yi, M. A., Son, H. M., Lee, J. S., Kwon, C. S., Lim, J. K., Yeo, Y. K., et al. (2002). Regulation of male sex hormone levels by soy isoflavones in rats. Nutrition and Cancer, 42, 206-210.